Oxidative Stress and Lung Ischemia-Reperfusion Injury

Oxidative Medicine and Cellular Longevity

Volumn 2015, Issue , 2015, Pages

  Ferrari, Renata Salatti ^a,b   Andrade, Cristiano Feijó ^a,b  

^a Clinical Hospital of Porto Alegre   (Brazil)

^b FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTHELIAL CELLS; OXYGEN;

CARDIOPULMONARY BYPASS; COMPLEMENT SYSTEMS; CRITICALLY-ILL PATIENTS; ISCHEMIA REPERFUSION; ISCHEMIA-REPERFUSION INJURY; LUNG TRANSPLANTATION; REACTIVE OXYGEN SPECIES; VASCULAR PERMEABILITY;

BIOLOGICAL ORGANS;

ACETYLCYSTEINE; ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); ANTIOXIDANT; CALCIUM; CALCIUM CHANNEL BLOCKING AGENT; IRON; NITRIC OXIDE; PROSTAGLANDIN E1; PROSTAGLANDIN E2; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN; AUTACOID; CALCIUM CHANNEL; REACTIVE OXYGEN METABOLITE; SODIUM CHANNEL;

APOPTOSIS; CELL DAMAGE; ENDOTHELIUM; HUMAN; IMMUNE RESPONSE; INFLAMMATION; LEUKOCYTE ACTIVATION; LUNG; LUNG INJURY; LUNG ISCHEMIA REPERFUSION INJURY; LYMPHOCYTE; NONHUMAN; OXIDATIVE STRESS; REPERFUSION INJURY; REVIEW; ANIMAL; METABOLISM; PATHOLOGY;

ANIMALIA;

ANIMALS; ANTIOXIDANTS; CALCIUM CHANNELS; HUMANS; INFLAMMATION MEDIATORS; LUNG; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; REPERFUSION INJURY; SODIUM CHANNELS;

EID: 84934280830     PISSN: 19420900     EISSN: 19420994     Source Type: Journal    
DOI: 10.1155/2015/590987     Document Type: Review

References (141)

1. W. G. S. Bonservizi, M. K. Koike, R. Saurim et al., "Ischemic preconditioning and atenolol on lung injury after intestinal ischemia and reperfusion in rats", Transplantation Proceedings, vol. 46, no. 6, pp. 1862-1866, 2014.
2. B. V. Pinheiro, M. A. Holanda, F. G. Araujo, and H. Romaldini, "Lesão pulmonar de reperfusão", Jornal Brasileiro de Pneumologia, vol. 25, no. 2, pp. 124-136, 1999.
3. D. M. Yellon and D. J. Hausenloy, "Myocardial reperfusion injury", The New England Journal of Medicine, vol. 357, no. 11, pp. 1121-1135, 2007.
4. M. Mura, C. F. Andrade, B. Han et al., "Intestinal ischemiareperfusioninduced acute lung injury and oncotic cell death in multiple organs", Shock, vol. 28, no. 2, pp. 227-238, 2007.
5. B. J. Zimmerman and D. N. Granger, "Mechanisms of reperfusion injury", The American Journal of the Medical Sciences, vol. 307, no. 4, pp. 284-292, 1994.
6. S. Ogawa, H. Gerlach, C. Esposito, A. Pasagian-Macaulay, J. Brett, and D. Stern, "Hypoxia modulates the barrier and coagulant function of cultured bovine endothelium. Increasedmonolayer permeability and induction of procoagulant properties", Journal of Clinical Investigation, vol. 85, no. 4, pp. 1090-1098, 1990.
7. M. D. Menger, "Microcirculatory disturbances secondary to ischemia-reperfusion", Transplantation Proceedings, vol. 27, no. 5, pp. 2863-2865, 1995.
8. W. Dröge, "Free radicals in the physiological control of cell function", Physiological Reviews, vol. 82, no. 1, pp. 47-95, 2002.
9. S. N. Jerome, M. Dore, J. C. Paulson, C. W. Smith, and R. J. Korthuis, "P-selectin and ICAM-1-dependent adherence reactions: role in the genesis of postischemic no-reflow", The American Journal of Physiology-Heart and Circulatory Physiology, vol. 266, part 2, no. 4, pp. H1316-H1321, 1994.
10. S. Cuzzocrea, D. P. Riley, A. P. Caputi, and D. Salvemini, "Antioxidant therapy: a new pharmacological approach in shock, inflammation, and ischemia/reperfusion injury", Pharmacological Reviews, vol. 53, no. 1, pp. 135-159, 2001.
11. T. P. Dalton, H. G. Shertzer, and A. Puga, "Regulation of gene expression by reactive oxygen", Annual Review of Pharmacology and Toxicology, vol. 39, pp. 67-101, 1999.
12. K. N. De Campos, S. Keshavjee, M. Liu, and A. S. Slutsky, "Prevention of rapid reperfusion-induced lung injury with prostaglandin E1 during the initial period of reperfusion", Journal of Heart and Lung Transplantation, vol. 17, no. 11, pp. 1121-1128, 1998.
13. C. Iadecola and J. Anrather, "The immunology of stroke: from mechanisms to translation", Nature Medicine, vol. 17, no. 7, pp. 796-808, 2011.
14. K. E. De Greef, D. K. Ysebaert, M. Ghielli et al., "Neutrophils and acute ischemia-reperfusion injury", Journal of Nephrology, vol. 11, no. 3, pp. 110-122, 1998.
15. S. Oredsson, G. Plate, and P. Qvarfordt, "Experimental evaluation of oxygen free radical scavengers in the prevention of reperfusion injury in skeletal muscle", European Journal of Surgery, vol. 160, no. 2, pp. 97-103, 1994.
16. P. A. Southorn and G. Powis, "Free radicals in medicine. II. Involvement in human disease", Mayo Clinic Proceedings, vol. 63, no. 4, pp. 390-408, 1988.
17. G. Ambrosio and I. Tritto, "Reperfusion injury: experimental evidence and clinical implications", American Heart Journal, vol. 138, no. 2, part 2, pp. S69-S75, 1999.
18. R. C. King, O. A. R. Binns, F. Rodriguez et al., "Reperfusion injury significantly impacts clinical outcome after pulmonary transplantation", Annals of Thoracic Surgery, vol. 69, no. 6, pp. 1681-1685, 2000.
19. J. D. Cooper, G. A. Patterson, E. P. Trulock et al., "Results of single and bilateral lung transplantation in 131 consecutive recipients", Journal of Thoracic and Cardiovascular Surgery, vol. 107, no. 2, pp. 460-471, 1994.
20. P. M. Reilly, H. J. Schiller, and G. B. Bulkley, "Pharmacologic approach to tissue injury mediated by free radicals and other reactive oxygen metabolites", American Journal of Surgery, vol. 161, no. 4, pp. 488-503, 1991.
21. J. V. Conte and W. A. Baumgartner, "Overview and future practice patterns in cardiac and pulmonary preservation", Journal of Cardiac Surgery, vol. 15, no. 2, pp. 91-107, 2000.
22. C.-K. Sun, C.-H. Yen, Y.-C. Lin et al., "Autologous transplantation of adipose-derived mesenchymal stem cells markedly reduced acute ischemia-reperfusion lung injury in a rodent model", Journal of Translational Medicine, vol. 9, no. 1, article 118, 2011.
23. G. Ucar, E. Topaloglu, H. B. Kandilci, and B. Gümüsel, "Effect of ischemic preconditioning on reactive oxygen species-mediated ischemia-reperfusion injury in the isolated perfused rat lung", Clinical Biochemistry, vol. 38, no. 7, pp. 681-684, 2005.
24. M. de Perrot, M. Liu, T. K. Waddell, and S. Keshavjee, "Ischemia-reperfusion-induced lung injury", American Journal of Respiratory and Critical Care Medicine, vol. 167, no. 4, pp. 490-511, 2003.
25. R. J. Novick, K. E. Gehman, I. S. Ali, and J. Lee, "Lung preservation: the importance of endothelial and alveolar type II cell integrity", Annals of Thoracic Surgery, vol. 62, no. 1, pp. 302-314, 1996.
26. J. D. Puskas, T. Hirai, N. Christie, E. Mayer, A. S. Slutsky, and G. A. Patterson, "Reliable thirty-hour lung preservation by donor lung hyperinflation", Journal of Thoracic and Cardiovascular Surgery, vol. 104, no. 4, pp. 1075-1083, 1992.
27. H. Date, A. Matsumura, J. K. Manchester et al., "Evaluation of lung metabolism during successful twenty-four-hour canine lung preservation", Journal of Thoracic and Cardiovascular Surgery, vol. 105, no. 3, pp. 480-491, 1993.
28. R. G. Eckenhoff, C. Dodia, Z. Tan, and A. B. Fisher, "Oxygendependent reperfusion injury in the isolated rat lung", Journal of Applied Physiology, vol. 72, no. 4, pp. 1454-1460, 1992.
29. C.-H. Chiang, H.-I. Pai, and S.-L. Liu, "Ventilator-induced lung injury (VILI) promotes ischemia/reperfusion lung injury (I/R) and NF-k B antibody attenuates both injuries", Resuscitation, vol. 79, no. 1, pp. 147-154, 2008.
30. I. Rahman, J. Marwick, and P. Kirkham, "Redox modulation of chromatin remodeling: impact on histone acetylation and deacetylation, NF-κB and pro-inflammatory gene expression", Biochemical Pharmacology, vol. 68, no. 6, pp. 1255-1267, 2004.
31. A. B. Al-Mehdi, H. Shuman, and A. B. Fisher, "Intracellular generation of reactive oxygen species during nonhypoxic lung ischemia", American Journal of Physiology-Lung Cellular and Molecular Physiology, vol. 272, no. 2, part 1, pp. L294-L300, 1997.
32. W. G. Land, "The role of postischemic reperfusion injury and other nonantigen-dependent inflammatory pathways in transplantation", Transplantation, vol. 79, no. 5, pp. 505-514, 2005.
33. R. L. Torres, L. K. Martins, M. Picoral et al., "The potential protective effect of low potassium dextran against lipid peroxidation in a rat lung transplantation model", The Thoracic and Cardiovascular Surgeon, vol. 57, no. 5, pp. 309-311, 2009.
34. R. F. Kelly, J. Murar, Z. Hong et al., "Lowpotassiumdextran lung preservation solution reduces reactive oxygen species production", Annals of Thoracic Surgery, vol. 75, no. 6, pp. 1705-1710, 2003.
35. H. Esme, H. Fidan, T. Koken, and O. Solak, "Effect of lung ischemia-reperfusion on oxidative stress parameters of remote tissues", European Journal of Cardio-Thoracic Surgery, vol. 29, no. 3, pp. 294-298, 2006.
36. M. A. McMillen, M. Huribal, and B. Sumpio, "Common pathway of endothelial-leukocyte interaction in shock, ischemia, and reperfusion", The American Journal of Surgery, vol. 166, no. 5, pp. 557-562, 1993.
37. R. S. Ferrari, D. P. da Rosa, L. F. Forgiarini, S. Bona, A. S. Dias, and N. P. Marroni, "Oxidative stress and pulmonary changes in experimental liver cirrhosis", Oxidative Medicine and Cellular Longevity, vol. 2012, Article ID 486190, 8 pages, 2012.
38. H. K. Eltzschig and T. Eckle, "Ischemia and reperfusion-from mechanism to translation", Nature Medicine, vol. 17, no. 11, pp. 1391-1401, 2011.
39. A. Grenz, E. Clambey, and H. K. Eltzschig, "Hypoxia signaling during intestinal ischemia and inflammation", Current Opinion in Critical Care, vol. 18, no. 2, pp. 178-185, 2012.
40. S. W. Park, M. Kim, K. M. Brown, V. D. D'Agati, and H. T. Lee, "Paneth cell-derived interleukin-17A causes multiorgan dysfunction after hepatic ischemia and reperfusion injury", Hepatology, vol. 53, no. 5, pp. 1662-1675, 2011.
41. G. Zhao, I. S. Ayene, and A. B. Fisher, "Role of iron in ischemiareperfusion oxidative injury of rat lungs", American Journal of Respiratory Cell and Molecular Biology, vol. 16, no. 3, pp. 293-299, 1997.
42. I. Inci, B. Erne, S. Arni et al., "Prevention of primary graft dysfunction in lung transplantation by N-acetylcysteine after prolonged cold ischemia", Journal of Heart and Lung Transplantation, vol. 29, no. 11, pp. 1293-1301, 2010.
43. H. T. Lee, S. W. Park, M. Kim, and V. D. D'Agati, "Acute kidney injury after hepatic ischemia and reperfusion injury in mice", Laboratory Investigation, vol. 89, no. 2, pp. 196-208, 2009.
44. L. E. C. Miranda, V. K. Capellini, G. S. Reis, A. C. Celotto, C. G. Carlotti Jr., and P. R. B. Evora, "Effects of partial liver ischemia followed by global liver reperfusion on the remote tissue expression of nitric oxide synthase: lungs and kidneys", Transplantation Proceedings, vol. 42, no. 5, pp. 1557-1562, 2010.
45. B. Halliwell, "Biochemistry of oxidative stress", Biochemical Society Transactions, vol. 35, part 5, pp. 1147-1150, 2007.
46. M. Zafarullah, W. Q. Li, J. Sylvester, and M. Ahmad, "Molecular mechanisms of N-acetylcysteine actions", Cellular and Molecular Life Sciences, vol. 60, no. 1, pp. 6-20, 2003.
47. R. L. Paterson, H. F. Galley, and N. R. Webster, "The effect of N-acetylcysteine on nuclear factor-κB activation, interleukin-6, interleukin-8, and intercellular adhesion molecule-1 expression in patients with sepsis", Critical Care Medicine, vol. 31, no. 11, pp. 2574-2578, 2003.
48. J. L. Farber, K. R. Chien, and S. Mittnacht Jr., "Myocardial ischemia: the pathogenesis of irreversible cell injury in ischemia", The American Journal of Pathology, vol. 102, no. 2, pp. 271-281, 1981.
49. G. Sener, O. Tosun, A. Ö. Şehirli et al., "Melatonin and Nacetylcysteine have beneficial effects during hepatic ischemia and reperfusion", Life Sciences, vol. 72, no. 24, pp. 2707-2718, 2003.
50. I. Ziment, "Acetylcysteine: a drug that is much more than a mucokinetic", Biomedicine and Pharmacotherapy, vol. 42, no. 8, pp. 513-519, 1988.
51. B. Särnstrand, A. Tunek, K. Sjödin, and A. Hallberg, "Effects of N-acetylcysteine stereoisomers on oxygen-induced lung injury in rats", Chemico-Biological Interactions, vol. 94, no. 2, pp. 157-164, 1995.
52. O. I. Aruoma, B. Halliwell, B. M. Hoey, and J. Butler, "The antioxidant action of N-acetylcysteine: its reaction with hydrogen peroxide, hydroxyl radical, superoxide, and hypochlorous acid", Free Radical Biology & Medicine, vol. 6, no. 6, pp. 593-597, 1989.
53. L. Bonanomi and A. Gazzaniga, "Toxicological, pharmacokinetic and metabolic studies on acetylcysteine", European Journal of Respiratory Diseases, vol. 61, no. 111, pp. 45-51, 1980.
54. R. C. Sprong, A. Miranda, L. Winkelhuyzen-Janssen et al., "Low-dose N-acetylcysteine protects rats against endotoxinmediated oxidative stress, but high-dose increases mortality", The American Journal of Respiratory and Critical Care Medicine, vol. 157, no. 4, part 1, pp. 1283-1293, 1998.
55. J. Bakker, H. Zhang, M. Depierreux, S. van Asbeck, and J.-L. Vincent, "Effects of N-acetylcysteine in endotoxic shock", Journal of Critical Care, vol. 9, no. 4, pp. 236-243, 1994.
56. S. Bergamini, C. Rota, R. Canali et al., "N-acetylcysteine inhibits in vivo nitric oxide production by inducible nitric oxide synthase", Nitric Oxide, vol. 5, no. 4, pp. 349-360, 2001.
57. S. Cuzzocrea, E. Mazzon, G. Costantino, I. Serraino, A. De Sarro, and A. P. Caputi, "Effects of n-acetylcysteine in a rat model of ischemia and reperfusion injury", Cardiovascular Research, vol. 47, no. 3, pp. 537-548, 2000.
58. H. Türüt, H. Ciralik, M. Kilinc, D. Ozbag, and S. S. Imrek, "Effects of early administration of dexamethasone, N-acetylcysteine and aprotinin on inflammatory and oxidantantioxidant status after lung contusion in rats", Injury, vol. 40, no. 5, pp. 521-527, 2009.
59. Y.-S. Kim, D.-Y. Jhon, and K.-Y. Lee, "Involvement of ROS and JNK1 in selenite-induced apoptosis in chang liver cells", Experimental & Molecular Medicine, vol. 36, no. 2, pp. 157-164, 2004.
60. N. Geudens, C. van de Wauwer, A. P. Neyrinck et al., "Nacetyl cysteine pre-treatment attenuates inflammatory changes in the warm ischemic murine lung", Journal of Heart and Lung Transplantation, vol. 26, no. 12, pp. 1326-1332, 2007.
61. L. F. Forgiarini, L. A. Forgiarini Jr., D. P. da Rosa, M. B. Silva, R. Mariano, and A. D. Paludo, "N-acetylcysteine administration confers lung protection in different phases of lung ischemiareperfusion injury", Interactive Cardio Vascular and Thoracic Surgery, vol. 19, no. 6, pp. 894-899, 2014.
62. N.-C. Wu, T.-H. Chen, Y.-C. Yang, F.-T. Liao, J.-C. Wang, and J.-J. Wang, "N-acetylcysteine improves cardiac contractility and ameliorates myocardial injury in a rat model of lung ischemia and reperfusion injury", Transplantation Proceedings, vol. 45, no. 10, pp. 3550-3554, 2013.
63. Ö. Çakir, A. Oruc, S. Kaya, N. Eren, F. Yildiz, and L. Erdinc, "N-acetylcysteine reduces lung reperfusion injury after deep hypothermia and total circulatory arrest", Journal of Cardiac Surgery, vol. 19, no. 3, pp. 221-225, 2004.
64. S. Cuzzocrea, M. C. McDonald, E. Mazzon et al., "Beneficial effects of tempol, a membrane-permeable radical scavenger, in a rodentmodel of splanchnic artery occlusion and reperfusion", Shock, vol. 14, no. 2, pp. 150-156, 2000.
65. C. J. Davreux, I. Soric, A. B. Nathens et al., "N-acetyl cysteine attenuates acute lung injury in the rat", Shock, vol. 8, no. 6, pp. 432-438, 1997.
66. Z.-Y. Huang, Z.-Y. Xia, D. M. Ansley, and B. S. Dhaliwal, "Clinical significance of plasma free 15-F2t-isoprostane concentration during coronary artery bypasses graft surgery", Zhongguo Wei Zhong Bing Ji Jiu Yi Xue, vol. 16, no. 3, pp. 165-168, 2004.
67. X. Mao, T. Wang, Y. Liu et al., "N-acetylcysteine and allopurinol confer synergy in attenuating myocardial ischemia injury via restoring HIF-1alpha/HO-1 signaling in diabetic rats", PLoS ONE, vol. 8, no. 7, Article ID e68949, 2013.
68. T. Wang, X. Mao, H. Li et al., "N-acetylcysteine and allopurinol up-regulated the Jak/STAT3 and PI3K/Akt pathways via adiponectin and attenuated myocardial postischemic injury in diabetes", Free Radical Biology and Medicine, vol. 63, pp. 291-303, 2013.
69. H. Nakano, K. Boudjema, E. Alexandre et al., "Protective effects of N-acetylcysteine on hypothermic ischemia-reperfusion injury of rat liver", Hepatology, vol. 22, no. 2, pp. 539-545, 1995.
70. K. Waxman, "Shock: ischemia, reperfusion, and inflammation", New Horizons: Science and Practice of Acute Medicine, vol. 4, no. 2, pp. 153-160, 1996.
71. L. B. Ware, J. A. Golden, W. E. Finkbeiner, and M. A. Matthay, "Alveolar epithelial fluid transport capacity in reperfusion lung injury after lung transplantation", American Journal of Respiratory and Critical Care Medicine, vol. 159, no. 3, pp. 980-988, 1999.
72. 2+ in ischemia-reperfusion injury in the isolated perfused rat liver", Circulatory Shock, vol. 37, no. 3, pp. 209-219, 1992.
73. S. Chatterjee and A. B. Fisher, "ROS to the rescue", American Journal of Physiology-Lung Cellular and Molecular Physiology, vol. 287, no. 4, pp. L704-L705, 2004.
74. G. M. Rosen and B. A. Freeman, "Detection of superoxide generated by endothelial cells", Proceedings of the National Academy of Sciences of the United States of America, vol. 81, no. 23, pp. 7269-7273, 1984.
75. I. Takeyoshi, K. Iwanami, N. Kamoshita et al., "Effect of lazaroid U-74389G on pulmonary ischemia-reperfusion injury in dogs", Journal of Investigative Surgery, vol. 14, no. 2, pp. 83-92, 2001.
76. M. C. Carroll and V. M. Holers, "Innate autoimmunity", Advances in Immunology, vol. 86, pp. 137-157, 2005.
77. G. Y. Chen and G. Nuñez, "Sterile inflammation: Sensing and reacting to damage", Nature Reviews Immunology, vol. 10, no. 12, pp. 826-837, 2010.
78. D. N. Granger, M. E. Hollwarth, and D. A. Parks, "Ischemiareperfusion injury: role of oxygen-derived free radicals", Acta Physiologica Scandinavica, vol. 126, no. 548, pp. 47-63, 1986.
79. C. F. Andrade, H. Kaneda, S. der et al., "Toll-like receptor and cytokine gene expression in the early phase of human lung transplantation", Journal of Heart and Lung Transplantation, vol. 25, no. 11, pp. 1317-1323, 2006.
80. J. T. Ambros, I. Herrero-Fresneda, O. G. Borau, and J. M. G. Boira, "Ischemic preconditioning in solid organ transplantation: from experimental to clinics", Transplant International, vol. 20, no. 3, pp. 219-229, 2007.
81. S. Uhlig, R. Göggel, and S. Engel, "Mechanisms of plateletactivating factor (PAF)-mediated responses in the lung", Pharmacological Reports, vol. 57, supplement, pp. 206-221, 2005.
82. I. S. Farrukh, J. R. Michael, S. P. Peters et al., "The role of cyclooxygenase and lipoxygenase mediators in oxidantinduced lung injury", American Review of Respiratory Disease, vol. 137, no. 6, pp. 1343-1349, 1988.
83. M. de Perrot, S. Fischer, M. Liu et al., "Prostaglandin E1 protects lung transplants from ischemia-reperfusion injury: a shift from pro-to anti-inflammatory cytokines", Transplantation, vol. 72, no. 9, pp. 1505-1512, 2001.
84. Y. Matsuzaki, T. K. Waddell, J. D. Puskas et al., "Amelioration of post-ischemic lung reperfusion injury by prostaglandin E1", American Review of Respiratory Disease, vol. 148, no. 4, part 1, pp. 882-889, 1993.
85. E. M. Drost and W. MacNee, "Potential role of IL-8, plateletactivating factor and TNF-alpha in the sequestration of neutrophils in the lung: effects on neutrophil deformability, adhesion receptor expression, and chemotaxis", European Journal of Immunology, vol. 32, no. 2, pp. 393-403, 2002.
86. C. K. Grissom, J. F. Orme Jr., L. D. Richer, T. M. McIntyre, G. A. Zimmerman, and M. R. Elstad, "Platelet-activating factor acetylhydrolase is increased in lung lavage fluid from patients with acute respiratory distress syndrome", Critical Care Medicine, vol. 31, no. 3, pp. 770-775, 2003.
87. S.-H. Back, J.-Y. Kim, J.-H. Choi et al., "Reduced glutathione oxidation ratio and 8 ohd G accumulation by mild ischemic pretreatment", Brain Research, vol. 856, no. 1-2, pp. 28-36, 2000.
88. K. Yoshimura, S. Nakagawa, S. Koyama, T. Kobayashi, and T. Homma, "Roles of neutrophil elastase and superoxide anion in leukotriene B4-induced lung injury in rabbit", Journal of Applied Physiology, vol. 76, no. 1, pp. 91-96, 1994.
89. G. Perrin, A. Roch, P. Michelet et al., "Inhaled nitric oxide does not prevent pulmonary edema after lung transplantation measured by lung water content: a randomized clinical study", Chest, vol. 129, no. 4, pp. 1024-1030, 2006.
90. C. M. Hart, "Nitric oxide in adult lung disease", Chest, vol. 115, no. 5, pp. 1407-1417, 1999.
91. N. Marczin, B. Riedel, J. Gal, J. Polak, and M. Yacoub, "Exhaled nitric oxide during lung transplantation", The Lancet, vol. 350, no. 9092, pp. 1681-1682, 1997.
92. T. D. le Cras and I. F. McMurtry, "Nitric oxide production in the hypoxic lung", The American Journal of Physiology-Lung Cellular and Molecular Physiology, vol. 280, no. 4, pp. L575-L582, 2001.
93. S. M. Fiser, C. G. Tribble, S. M. Long et al., "Lung transplant reperfusion injury involves pulmonarymacrophages and circulating leukocytes ina biphasic response", Journal of Thoracic and Cardiovascular Surgery, vol. 121, no. 6, pp. 1069-1075, 2001.
94. M. J. Eppinger, G. M. Deeb, S. F. Bolling, and P. A. Ward, "Mediators of ischemia-reperfusion injury of rat lung", The American Journal of Pathology, vol. 150, no. 5, pp. 1773-1784, 1997.
95. N. Richter, G. Raddatz, G. Steinhoff, H.-J. Schafers, and H. J. Schlitt, "Transmission of donor lymphocytes in clinical lung transplantation", Transplant International, vol. 7, no. 6, pp. 414-419, 1994.
96. J. Sperling, J. Chebath, H. Arad-Dann et al., "Possible involvement of (2'-5') oligoadenylate synthetase activity in pre-m RNA splicing", Proceedings of the National Academy of Sciences of the United States of America, vol. 88, no. 23, pp. 10377-10381, 1991.
97. C. R. B. Welbourn, G. Goldman, I. S. Paterson, C. R. Valeri, D. Shepro, and H. B. Hechtman, "Neutrophil elastase and oxygen radicals: Synergism in lung injury after hindlimb ischemia", The American Journal of Physiology-Heart and Circulatory Physiology, vol. 260, no. 6, part 2, pp. H1852-H1856, 1991.
98. G. M. Deeb, C. M. Grum, M. J. Lynch et al., "Neutrophils are not necessary for induction of ischemia-reperfusion lung injury", Journal of Applied Physiology, vol. 68, no. 1, pp. 374-381, 1990.
99. M. B. Parolin and I. J. Messias Reason, "Apoptosis as a mechanism of tissue injury in hepatobiliary diseases", Arquivos de Gastroenterologia, vol. 38, no. 2, pp. 138-144, 2001.
100. U. Stammberger, A. Gaspert, S. Hillinger et al., "Apoptosis induced by ischemia and reperfusion in experimental lung transplantation", Annals of Thoracic Surgery, vol. 69, no. 5, pp. 1532-1536, 2000.
101. J. A. C. de Souza, C. Rossa Junior, G. P. Garlet, A. V. B. Nogueira, and J. A. Cirelli, "Modulationofhost cell signaling pathways as a therapeutic approach in periodontal disease", Journal of Applied Oral Science, vol. 20, no. 2, pp. 128-138, 2012.
102. D. Rossi and G. Gaidano, "Messengers of cell death: apoptotic signaling in health and disease", Haematologica, vol. 88, no. 2, pp. 212-218, 2003.
103. H. Y. Chang and X. Yang, "Proteases for cell suicide: functions and regulation of caspases", Microbiology and Molecular Biology Reviews, vol. 64, no. 4, pp. 821-846, 2000.
104. K. Kuwano and N. Hara, "Signal transduction pathways of apoptosis and inflammation induced by the tumor necrosis factor receptor family", The American Journal of Respiratory Cell and Molecular Biology, vol. 22, no. 2, pp. 147-149, 2000.
105. A. E. Greijer and E. van der Wall, "The role of hypoxia inducible factor 1 (HIF-1) in hypoxia induced apoptosis", Journal of Clinical Pathology, vol. 57, no. 10, pp. 1009-1014, 2004.
106. H. A. de Schepop, J. S. de Jong, P. J. van Diest, and J. P. A. Baak, "Counting of apoptotic cells: amethodological study in invasive breast cancer", Journal of Clinical Pathology-Clinical Molecular Pathology, vol. 49, no. 4, pp. M214-M217, 1996.
107. D. S. McClintock, M. T. Santore, V. Y. Lee et al., "Bc1-2 family members and functional electron transport chain regulate oxygen deprivation-induced cell death", Molecular and Cellular Biology, vol. 22, no. 1, pp. 94-104, 2002.
108. L. A. Forgiarini, G. Grün, N. A. Kretzmann et al., "When is injury potentially reversible in a lung ischemia-reperfusion model?" Journal of Surgical Research, vol. 179, no. 1, pp. 168-174, 2013.
109. A. Gross, X. M. Yin, K. Wang et al., "Caspase cleaved BIDtargets mitochondria and is required for cytochrome c release, while BCL-X (L) prevents this release but not tumor necrosis factor-R1/Fas death", The Journal of Biological Chemistry, vol. 274, no. 2, pp. 1156-1163, 1999.
110. M. C. Wei, W. X. Zong, E. H. Y. Cheng et al., "Proapoptotic BAX and BAK: a requisite gateway tomitochondrial dysfunction and death", Science, vol. 292, no. 5517, pp. 727-730, 2001.
111. P. Li, D. Nijhawan, I. Budihardjo et al., "Cytochrome c and d ATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade", Cell, vol. 91, no. 4, pp. 479-489, 1997.
112. D. W. Nicholson and N. A. Thornberry, "Caspases: killer proteases", Trends in Biochemical Sciences, vol. 22, no. 8, pp. 299-306, 1997.
113. L. de Kerchove, M. Boodhwani, P.-Y. Etienne et al., "Preservation of the pulmonary autograft after failure of the Ross procedure", European Journal of Cardio-Thoracic Surgery, vol. 38, no. 3, pp. 326-332, 2010.
114. M. de Perrot and S. Keshavjee, "Lung preservation", Seminars in Thoracic and Cardiovascular Surgery, vol. 16, no. 4, pp. 300-308, 2004.
115. Y. X. Zhang, H. Fan, Y. Shi et al., "Prevention of lung ischemiareperfusion injury by short hairpin RNA-mediated caspase-3 gene silencing", Journal of Thoracic and Cardiovascular Surgery, vol. 139, no. 3, pp. 758-764, 2010.
116. A. M. D'Armini, C. S. Roberts, P. K. Griffith, J. J. Lemasters, and T. M. Egan, "When does the lung die? I. Histochemical evidence of pulmonary viability after 'death'", Journal of Heart and Lung Transplantation, vol. 13, no. 5, pp. 741-747, 1994.
117. S. Chien, F. Zhang, W. Niu, M. T. Tseng, and L. Gray Jr., "Comparison of university of wisconsin, euro-collins, low-potassium dextran, and krebs-henseleit solutions for hypothermic lung preservation", Journal of Thoracic and Cardiovascular Surgery, vol. 119, no. 5, pp. 921-930, 2000.
118. A. Alvarez, A. Salvatierra, R. Lama et al., "Preservation with a retrograde second flushing of eurocollins in clinical lung transplantation", Transplantation Proceedings, vol. 31, no. 1-2, pp. 1088-1090, 1999.
119. C. Z. Chen, R. C. Gallagher, P. Ardery, W. Dyckman, and H. B. C. Low, "Retrograde versus antegrade flush in canine left lung preservation for six hours", Journal of Heart and Lung Transplantation, vol. 15, no. 4, pp. 395-403, 1996.
120. J.-I. Oyama, C. Blais Jr., X. Liu et al., "Reduced myocardial ischemia-reperfusion injury in toll-like receptor 4-deficient mice", Circulation, vol. 109, no. 6, pp. 784-789, 2004.
121. L. A. Forgiarini Jr., L. F. Forgiarini, D. P. Da Rosa, R. Mariano, J. M. Ulbrich, and C. F. Andrade, "Endobronchial perfluorocarbon administration decreases lung injury in an experimental model of ischemia and reperfusion", Journal of Surgical Research, vol. 183, no. 2, pp. 835-840, 2013.
122. L. A. Forgiarini Junior, A. R. R. Holand, L. F. Forgiarini et al., "Endobronchial perfluorocarbon reduces inflammatory activity before and after lung transplantation in an animal experimental model", Mediators of Inflammation, vol. 2013, Article ID 193484, 9 pages, 2013.
123. M. S. Bhabra, D. N. Hopkinson, T. E. Shaw, and T. L. Hooper, "Relative importance of prostaglandin/cyclic adenosine monophosphate and nitric oxide/cyclic guanosine monophosphate pathways in lung preservation", Annals of Thoracic Surgery, vol. 62, no. 5, pp. 1494-1499, 1996.
124. R. S. Bonser, L. S. Fragomeni, S. W. Jamieson et al., "Effects of prostaglandin E1, in twelve-hour lung preservation", Journal of Heart and Lung Transplantation, vol. 10, no. 2, pp. 310-316, 1991.
125. T. M. Egan, K. S. Ulicny, C. J. Lambert, and B. R. Wilcox, "Effect of a free radical scavenger on cadaver lung transplantation", The Annals of Thoracic Surgery, vol. 55, no. 6, pp. 1453-1459, 1993.
126. H. Itano, W. Zhang, J. H. Ritter, T. J. McCarthy, T. Mohanakumar, and G. A. Patterson, "Adenovirus-mediated gene transfer of human interleukin 10 ameliorates reperfusion injury of rat lung isografts", The Journal of Thoracic and Cardiovascular Surgery, vol. 120, no. 5, pp. 947-956, 2000.
127. E. S. Pilla, G. S. Vendrame, P. G. Sánchez et al., "Ischemic preconditioning by selective occlusion of the pulmonary artery in rats", Jornal Brasileiro de Pneumologia, vol. 34, no. 8, pp. 583-589, 2008.
128. R. S. Hotchkiss, A. Strasser, J. E. McDunn, and P. E. Swanson, "Mechanisms of disease: cell death", The New England Journal of Medicine, vol. 361, no. 16, pp. 1570-1583, 2009.
129. C. V. Thakar, K. Zahedi, M. P. Revelo et al., "Identification of thrombospondin 1 (TSP-1) as a novel mediator of cell injury in kidney ischemia", The Journal of Clinical Investigation, vol. 115, no. 12, pp. 3451-3459, 2005.
130. Z. Tang, P. Arjunan, C. Lee et al., "Survival effect of PDGFCC rescues neurons from apoptosis in both brain and retina by regulating GSK3β phosphorylation", Journal of Experimental Medicine, vol. 207, no. 4, pp. 867-880, 2010.
131. I. M. Verma, "Severe liver degeneration in mice lacking the IκB kinase 2 gene", Science, vol. 284, no. 5412, pp. 321-325, 1999.
132. T. Ishiyama, S. Dharmarajan, M. Hayama, H. Moriya, K. Grapperhaus, and G. A. Patterson, "Inhibition of nuclear factor κB by IκB superrepressor gene transfer ameliorates ischemiareperfusion injury after experimental lung transplantation", Journal of Thoracic and Cardiovascular Surgery, vol. 130, no. 1, pp. 194-201, 2005.
133. L.-W. Chen, L. Egan, Z.-W. Li, F. R. Greten, M. F. Kagnoff, and M. Karin, "The two faces of IKK and NF-κB inhibition: prevention of systemic inflammation but increased local injury following intestinal ischemia-reperfusion", Nature Medicine, vol. 9, no. 5, pp. 575-581, 2003.
134. L. Swoboda, D. E. Clancy, M. A. Donnebrink, and C. M. Rieder-Nelissen, "The influence of verapamil on lung preservation. A study on rabbit lungs with a reperfusion model allowing physiological loading", Thoracic and Cardiovascular Surgeon, vol. 41, no. 2, pp. 85-92, 1993.
135. C. F. Andrade, T. K. Waddell, S. Keshavjee, and M. Liu, "Innate immunity and organ transplantation: the potential role of tolllike receptors", The American Journal of Transplantation, vol. 5, no. 5, pp. 969-975, 2005.
136. H. Yamagishi, C. Yamashita, and M. Okada, "Preventive influence of inhaled nitric oxide on lung ischemia-reperfusion injury", Surgery Today, vol. 29, no. 9, pp. 897-901, 1999.
137. A. V. Ovechkin, D. Lominadze, K. C. Sedoris, E. Gozal, T. W. Robinson, and A. M. Roberts, "Inhibition of inducible nitric oxide synthase attenuates platelet adhesion in subpleural arterioles caused by lung ischemia-reperfusion in rabbits", Journal of Applied Physiology, vol. 99, no. 6, pp. 2423-2432, 2005.
138. H. Esme, H. Fidan, O. Solak, F. H. Dilek, R. Demirel, and M. Unlu, "Beneficial effects of supplemental nitric oxide donor given during reperfusion period in reperfusion-induced lung injury", Thoracic and Cardiovascular Surgeon, vol. 54, no. 7, pp. 477-483, 2006.
139. H. Yamashita, S. Akamine, Y. Sumida et al., "Inhaled nitric oxide attenuates apoptosis in ischemia-reperfusion injury of the rabbit lung", Annals of Thoracic Surgery, vol. 78, no. 1, pp. 292-297, 2004.
140. M. O. Meade, J. T. Granton, A. Matte-Martyn et al., "A randomized trial of inhaled nitric oxide to prevent ischemiareperfusion injury after lung transplantation", The American Journal of Respiratory and Critical Care Medicine, vol. 167, no. 11, pp. 1483-1489, 2003.
141. A. Ardehali, H. Laks, M. Levine et al., "A prospective trial of inhaled nitric oxide in clinical lung transplantation", Transplantation, vol. 72, no. 1, pp. 112-115, 2001.